Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
Cell Reports · 2024
DOI: 10.1016/j.celrep.2023.113629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Dimitris Karagiannis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Neoplasms, NF-E2-Related Factor 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA; Laura and Isaac Perlmutter NYU Cancer Center, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIH HHS
- NIDCR NIH HHS
Zitieren
APA
Karagiannis, D., Wu, W., Li, A., Hayashi, M., Chen, X., Yip, M., Mangipudy, V., Xu, X., Sánchez-Rivera, F. J., Soto-Feliciano, Y. M., Ye, J., Papagiannakopoulos, T., & Lu, C. (2024). Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113629
Vancouver
Karagiannis D, Wu W, Li A, Hayashi M, Chen X, Yip M, et al. Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors. Cell Reports. 2024. doi:10.1016/j.celrep.2023.113629
BibTeX
@article{Karagiannis2024,
author = {Karagiannis, Dimitris and Wu, Warren and Li, Albert and Hayashi, Makiko and Chen, Xiao and Yip, Michaela and Mangipudy, Vaibhav and Xu, Xinjing and Sánchez-Rivera, Francisco J and Soto-Feliciano, Yadira M and Ye, Jiangbin and Papagiannakopoulos, Thales and Lu, Chao},
title = {Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2023.113629}
}
EUVIMED